We narrowed to 41,376 results for: LAT;

#1000000133

A flexible modular system for advanced strain engineering in Pichia pastoris to accomplish pathway expression, protein production, or other DNA integration applications.

Brigitte Gasser

Feb. 20, 2018

Academic Institutions and Nonprofits only

#1000000255

Regulate gene expression by combining gRNA constructs targeting natural promoters and insertion of synthetic promoters in Yarrowia lipolytica.

Irina Borodina

April 28, 2025

Academic Institutions and Nonprofits only

#232069

Knockout library for use in CRASP-Seq experiments. Provides a flexible platform for studying splicing regulation.

Thomas Gonatopoulos-Pournatzis

Behera et al Mol Cell. 2026 Jan 8;86(1):41-59.e15. do

Oct. 28, 2025

Academic Institutions and Nonprofits only

#1000000244

Plasmids for inducible, linkage-specific polyubiquitylation of a protein of interest in human cells.

Helle Ulrich

May 31, 2024

Academic Institutions and Nonprofits only

#217744

Targets 56 transcription factors in Yarrowia lipolytica, enabling the knockout or modulation of expression levels for these factors.

Irina Borodina

May 20, 2025

Academic Institutions and Nonprofits only

#125753

Knockout library targeting a set of human interferon-stimulated genes (ISGs).

Michael Emerman, Molly OhAinle

Roesch et al Retrovirology. 2018 Mar 20;15(1):26. doi

May 7, 2020

Academic Institutions and Nonprofits only

#1000000197

Lentiviral plasmids with unique protein barcodes and gRNA cloning sites for CRISPR screens and tracking cell populations. Barcodes are linked to a nuclear-localizing mCherry fluorescent reporter. Part of the Pro-Code Vector Kits.

Brian Brown

Nov. 3, 2022

Academic Institutions and Nonprofits only

#1000000065

Plasmids consisting of open reading frames cloned into the pCellFree vector, which enables protein expression in any in vitro translation system.

Kirill Alexandrov

Nov. 6, 2015

Academic Institutions and Nonprofits only

#58909-AAV5

Ready-to-use AAV5 particles produced from pAAV-GFAP104-mCherry (#58909). In addition to the viral particles, you will also receive purified pAAV-GFAP104-mCherry plasmid DNA. GFAP104-driven mCherry expression control. These AAV preparations are suitable purity for injection into animals.

Edward Boyden

Perea et al Nat Commun. 2014;5:3262. doi: 10.1038/nc

Feb. 27, 2019

Academic Institutions and Nonprofits only

#191535

Targets 1,196 genes related to lipid droplet biology and cell metabolism.

James Olzmann

Roberts et al Dev Cell. 2023 Jul 18:S1534-5807(23)0033

March 1, 2023

Academic Institutions and Nonprofits only

#190744

Targets proximal poly(A) signal sequences in genes identified to be differentially polyadenylated in the mouse B16-F10 melanoma system.

Robert Bradley

Gabel et al Nat Commun. 2024 Feb 1;15(1):959. doi: 1

Feb. 2, 2024

Academic Institutions and Nonprofits only

#58892-AAV5

Ready-to-use AAV5 particles produced from pAAV-GFAP104-ChR2-mCherry (#58892). In addition to the viral particles, you will also receive purified pAAV-GFAP104-ChR2-mCherry plasmid DNA. GFAP -driven, expression of humanized ChR2 H134R mutant fused to mCherry, for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

Edward Boyden

Perea et al Nat Commun. 2014;5:3262. doi: 10.1038/nc

Jan. 14, 2026

Academic Institutions and Nonprofits only

#174112-AAV2

Ready-to-use AAV2 particles produced from pAAV-EF1a-mitoGFP-DIO (#174112). In addition to the viral particles, you will also receive purified pAAV-EF1a-mitoGFP-DIO plasmid DNA. EF1a-driven, Cre-dependent expression of mitochondria-targeted GFP. These AAV preparations are suitable purity for injection into animals.

Maarten Kole

Kole et al Nat Commun. 2022 Dec 9;13(1):7598. doi:

Aug. 7, 2025

Academic Institutions and Nonprofits only

#92207-AAV1

Ready-to-use AAV1 particles produced from TRE-ChrimsonR-mCherry (#92207). In addition to the viral particles, you will also receive purified TRE-ChrimsonR-mCherry plasmid DNA. TRE-driven ChrimsonR-mCherry expression for optogenetic neural activation. These AAV preparations are suitable purity for injection into animals.

Alice Ting

Wang et al Nat Biotechnol. 2017 Jun 26. doi: 10.103

Nov. 13, 2025

Academic Institutions and Nonprofits only

#100832-AAV1

Ready-to-use AAV1 particles produced from pAAV.hSyn.CaMPARI.WPRE.SV40 (#100832). In addition to the viral particles, you will also receive purified pAAV.hSyn.CaMPARI.WPRE.SV40 plasmid DNA. Synapsin-driven, photoconvertible (irreversible green-to-red) calcium integrator. These AAV preparations are suitable purity for injection into animals.

Loren Looger, Eric Schreiter

Fosque et al Science. 2015 Feb 13;347(6223):755-60. d

April 6, 2018

Academic Institutions and Nonprofits only

#100832-AAV9

Ready-to-use AAV9 particles produced from pAAV.hSyn.CaMPARI.WPRE.SV40 (#100832). In addition to the viral particles, you will also receive purified pAAV.hSyn.CaMPARI.WPRE.SV40 plasmid DNA. Synapsin-driven, photoconvertible (irreversible green-to-red) calcium integrator. These AAV preparations are suitable purity for injection into animals.

Loren Looger, Eric Schreiter

Fosque et al Science. 2015 Feb 13;347(6223):755-60. d

April 17, 2018

Academic Institutions and Nonprofits only

#100832-AAV5

Ready-to-use AAV5 particles produced from pAAV.hSyn.CaMPARI.WPRE.SV40 (#100832). In addition to the viral particles, you will also receive purified pAAV.hSyn.CaMPARI.WPRE.SV40 plasmid DNA. Synapsin-driven, photoconvertible (irreversible green-to-red) calcium integrator. These AAV preparations are suitable purity for injection into animals.

Loren Looger, Eric Schreiter

Fosque et al Science. 2015 Feb 13;347(6223):755-60. d

April 6, 2018

Academic Institutions and Nonprofits only

#1000000177

Lentiviral plasmids with unique protein barcodes and gRNA cloning sites for CRISPR screens and tracking cell populations. Part of the Pro-Code Vector Kits.

Brian Brown

Sept. 3, 2021

Academic Institutions and Nonprofits only

#1000000119

Collection of Golden Gate vectors and standardized genetic parts for the construction mammalian expression plasmids.

Yizhi Cai

March 1, 2018

Academic Institutions and Nonprofits only

#79871-AAV1

Ready-to-use AAV1 particles produced from pAAV-Ef1a-DIO_EGFP-GFE3 (#79871). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO_EGFP-GFE3 plasmid DNA. EF1a-driven, Cre-dependent expression of GFP-GFE3. These AAV preparations are suitable purity for injection into animals.

Don Arnold

Gross et al Nat Methods. 2016 Jun 6. doi: 10.1038/nm

Nov. 13, 2025

Academic Institutions and Nonprofits only